Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Rozlytrek (entrectinib (ROS1-Positive
.
Show all posts
Showing posts with label
Rozlytrek (entrectinib (ROS1-Positive
.
Show all posts
Tuesday, January 21, 2020
FDA Approves Rozlytrek (entrectinib) for People With ROS1-Positive, Metastatic Non-Small Cell Lung Cancer and NTRK Gene Fusion-Positive Solid Tumors
›
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced the U.S. Food and Drug Administration (FDA) has app...
›
Home
View web version
